Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000553952 | SCV000623935 | pathogenic | Primary ciliary dyskinesia | 2022-06-27 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 44-46 of the DNAH5 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant has not been reported in the literature in individuals affected with DNAH5-related conditions. This variant disrupts a region of the DNAH5 protein in which other variant(s) (p.Arg2501Pro) have been determined to be pathogenic (PMID: 16627867, 19357118, 25802884, 30067075, 32357925; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |